Last checked at 27 Sep 2021 09:31
LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual
LONDON BROKER RATINGS: Upgrades for Ferrexpo, Go-Ahead and Old Mutual
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades
HIK
Live RNS
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions
HIK
Media
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,973.00
Bid:
1,750.00
Ask:
2,222.00
Change:
0.00 (0.00%)
Spread:
472.00 (26.971%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
1,973.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.27 Sep 2021 09:28
UPDATE 2-Energy stocks, banks lift FTSE 100; Rolls-Royce top performer
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Rolls-Royce jumps on sales of Spain-based ITP, U.S. Air Force contract* Energy stocks track crude oil prices higher* Hikma Pharma gains o...
Read more27 Sep 2021 08:50
LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win
LONDON MARKET OPEN: Rolls-Royce rises on US Air Force contract win
Read more27 Sep 2021 08:16
TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million
TOP NEWS: Hikma buys US injectables firm Custopharm for USD375 million
Read more27 Sep 2021 07:49
LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract
LONDON MARKET PRE-OPEN: Rolls-Royce wins USD2.6 billion B-52 contract
Read more27 Sep 2021 07:05
Hikma buys Custopharm for $375m
(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.
Read more27 Sep 2021 07:05
Hikma buys Custopharm for $375m
(Sharecast News) - Hikma Pharmaceuticals said it was buying US firm Custopharm from Water Street Healthcare Partners for $375m on a debt and cash-free basis, with a further $50m payable on meeting certain commercial milestones.
Read more13 Sep 2021 16:09
2 Sep 2021 09:38
LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC
LONDON BROKER RATINGS: JPMorgan downgrades Unilever and Coca-Cola HBC
Read more27 Aug 2021 12:32
Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody
(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.
Read more20 Aug 2021 09:46
LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold
LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold
Read more20 Aug 2021 08:10
LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons
LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons
Read more17 Aug 2021 09:46
UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...
Read more12 Aug 2021 16:04
6 Aug 2021 17:06
LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report
LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report
Read more